Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Diabetic retinopathy. Background, classification, pathophysiology

R N Mames1

  • 1Retina Center, Gainesville 32605.

The Journal of the Florida Medical Association
|April 1, 1994
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Pars plana vitrectomy for the treatment of ophthalmomyiasis interna posterior in a dog.

Veterinary ophthalmology·2006
Same author

The efficacy of octreotide in the therapy of severe nonproliferative and early proliferative diabetic retinopathy: a randomized controlled study.

Diabetes care·2000
Same author

Photoreceptor outer segments in aqueous humor from dogs with rhegmatogenous retinal detachments.

Journal of the American Veterinary Medical Association·1997
Same author

Positive vitreous cultures from eyes without signs of infectious endophthalmitis.

Ophthalmic surgery and lasers·1997
Same author

Plasminogen activator inhibitor-1 overexpression in nonproliferative diabetic retinopathy.

Experimental eye research·1996
Same author

Diabetic iris neovascularization.

American journal of ophthalmology·1995
Same journal

The dawning of the age of accountability.

The Journal of the Florida Medical Association·1999
Same journal

Physician office-based quality improvement projects. Florida Medical Quality Assurance, Inc.

The Journal of the Florida Medical Association·1998
Same journal

Hyperlipidemia management in patients with cardiovascular and cerebrovascular disease.

The Journal of the Florida Medical Association·1998
Same journal

On the horizon: newly-developed quality improvement projects. Florida Medical Quality Assurance, Inc.

The Journal of the Florida Medical Association·1998
Same journal

Angiotensin converting enzyme inhibitor use in congestive heart failure. Florida Medical Quality Assurance, Inc.

The Journal of the Florida Medical Association·1998
Same journal

Influenza immunization among Medicare beneficiaries enrolled in a health maintenance organization: 1994. Florida Medical Quality Assurance, Inc.

The Journal of the Florida Medical Association·1998
See all related articles

Diabetic retinopathy, a leading cause of blindness, requires early detection and management. Effective treatment involves glucose control, timely interventions like laser photocoagulation, and future biological therapies.

Area of Science:

  • Ophthalmology
  • Endocrinology
  • Diabetic Complications

Background:

  • Diabetic retinopathy is the primary cause of legal blindness in working adults in the U.S.
  • Prolonged diabetes duration significantly increases the risk of developing retinopathy.
  • Accurate classification of retinopathy is essential for effective treatment and follow-up schedules.

Purpose of the Study:

  • To highlight the critical importance of classifying diabetic retinopathy for therapeutic decisions.
  • To emphasize the necessity of a collaborative approach in managing diabetic patients.
  • To discuss current and future treatment strategies for diabetic retinopathy.

Main Methods:

  • Review of current clinical practices and understanding of diabetic retinopathy pathophysiology.

Related Experiment Videos

  • Emphasis on early referral to ophthalmologists specializing in diabetic eye care.
  • Discussion of established and emerging treatment modalities.

    • Main Results:

    • Current management focuses on prevention via glucose control and early detection.
    • Laser photocoagulation and vitrectomy surgery are key interventions when necessary.
    • Advancements in understanding pathophysiology may lead to earlier biological interventions.

    Conclusions:

    • Effective management of diabetic retinopathy necessitates a team approach and timely specialist referral.
    • Prevention through glucose control and early detection remains paramount.
    • Future research holds promise for novel biological treatments for diabetic retinopathy.